CDK5 and Alzheimer disease: In this context, CDK5 may mediate alterations in neurogenesis in AD and HIVE via aberrant phosphorylation of its substrates, which include cytoskeletal (neurofilaments, nestin) [18] and synaptic proteins (e.g. synapsin) [19], among others.